Abstract
Deferoxamine (DFO) is a siderophore widely studied for its ability to bind iron(III) strongly. Thanks to its versatility, it is suitable for several clinical and analytical applications, from the recognized iron(III) chelation therapy to the most recent applications in sensing. The presence of three hydroxamic functional groups enables Deferoxamine to form stable complexes with iron(III) and other divalent and trivalent metal ions. Moreover, the terminal amino group in the DFO molecule, not involved in metal ion complexation, allows modification or functionalization of solid phases, nanoobjects, biopolymers, electrodes and optical devices. This review summarizes and discusses deferoxamine-based applications for the chelation and recognition of Fe(III).
Subject
Physical and Theoretical Chemistry,Analytical Chemistry
Reference85 articles.
1. Advances in the Chemical Biology of Desferrioxamine B;Codd;ACS Chem. Biol.,2018
2. Siderophores for medical applications: Imaging, sensors, and therapeutics;Fan;Int. J. Pharm.,2021
3. Boschke, F.L. Complexation of iron by siderophores a review of their solution and structural chemistry and biological function. Structural Chemistry: Topics in Current Chemistry, 1984. Volume 123.
4. Siderophore-based iron acquisition and pathogen control;Miethke;Microbiol. Mol. Biol. Rev.,2007
5. Deferoxamine Compensates for Decreases in B Cell Counts and Reduces Mortality in Enterovirus 71-Infected Mice;Yang;Mar. Drugs,2014
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献